OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in deubiquitinating enzymes in lung adenocarcinoma
Xijia Zhou, Rui Li, Xiao Liu, et al.
Journal of Cancer (2021) Vol. 12, Iss. 18, pp. 5573-5582
Open Access | Times Cited: 15
Xijia Zhou, Rui Li, Xiao Liu, et al.
Journal of Cancer (2021) Vol. 12, Iss. 18, pp. 5573-5582
Open Access | Times Cited: 15
Showing 15 citing articles:
Deubiquitinase USP18 mediates cell migration, apoptosis and ferroptosis in lung adenocarcinoma by depending on POU4F1/PRKAA2 axis
Xinping Pan, Hui Deng
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Xinping Pan, Hui Deng
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
The roles of protein ubiquitination in tumorigenesis and targeted drug discovery in lung cancer
Zhen Ye, Jingru Yang, Hanming Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
Zhen Ye, Jingru Yang, Hanming Jiang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 9
E3 ubiquitin ligases and deubiquitinases in bladder cancer tumorigenesis and implications for immunotherapies
Maoyu Wang, Zhensheng Zhang, Zhizhou Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Maoyu Wang, Zhensheng Zhang, Zhizhou Li, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
USP5: Comprehensive insights into structure, function, biological and disease-related implications, and emerging therapeutic opportunities
Siting Gao, Xin Xin, Zhuo-yuan Wang, et al.
Molecular and Cellular Probes (2023) Vol. 73, pp. 101944-101944
Open Access | Times Cited: 8
Siting Gao, Xin Xin, Zhuo-yuan Wang, et al.
Molecular and Cellular Probes (2023) Vol. 73, pp. 101944-101944
Open Access | Times Cited: 8
Ubiquitylation of RUNX3 by RNA-binding ubiquitin ligase MEX3C promotes tumorigenesis in lung adenocarcinoma
Zelai He, Huijun Zhang, Haibo Xiao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Zelai He, Huijun Zhang, Haibo Xiao, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
A Comprehensive Prognostic and Immune Analysis of Ferroptosis-Related Genes Identifies SLC7A11 as a Novel Prognostic Biomarker in Lung Adenocarcinoma
Qian Li, Fu Wang, Shumin Lu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 11
Qian Li, Fu Wang, Shumin Lu, et al.
Journal of Immunology Research (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 11
Identification of NR3C2 as a functional diagnostic and prognostic biomarker and potential therapeutic target in non‐small cell lung cancer
Yuan‐yuan Sun, Haicheng Gao, Peng Guo, et al.
Cancer Innovation (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Yuan‐yuan Sun, Haicheng Gao, Peng Guo, et al.
Cancer Innovation (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Circ_0001715 accelerated lung adenocarcinoma process by the miR-1322/CANT1 axis
Yue Niu, Lina Fan, Xiaoyu Shi, et al.
Diagnostic Pathology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Yue Niu, Lina Fan, Xiaoyu Shi, et al.
Diagnostic Pathology (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Recent Progress of Deubiquitinating Enzymes in Human and Plant Pathogenic Fungi
Weixiang Wang, Xuan Cai, Xiaolin Chen
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 4
Weixiang Wang, Xuan Cai, Xiaolin Chen
Biomolecules (2022) Vol. 12, Iss. 10, pp. 1424-1424
Open Access | Times Cited: 4
Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors
Jie Wang, Shizhen Fang, Yang Jiang, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
Jie Wang, Shizhen Fang, Yang Jiang, et al.
Clinical Medicine Insights Oncology (2024) Vol. 18
Open Access
AXL transcriptionally up-regulates TMEM14A expression to mediate cell proliferation in non-small-cell lung cancer cells
Te‐Hsuan Jang, Sheng‐Chieh Lin, Yayu Yang, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 365-370
Open Access | Times Cited: 1
Te‐Hsuan Jang, Sheng‐Chieh Lin, Yayu Yang, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 682, pp. 365-370
Open Access | Times Cited: 1
Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p
Jie Mei, Jing Zuo, Jiazhuan Mei, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 5, pp. 3504-3522
Closed Access | Times Cited: 1
Jie Mei, Jing Zuo, Jiazhuan Mei, et al.
Biochemical Genetics (2023) Vol. 62, Iss. 5, pp. 3504-3522
Closed Access | Times Cited: 1
Bioactive components and the molecular mechanism of Shengxian Decoction against lung adenocarcinoma based on network pharmacology and molecular docking.
Ruijiao Yuan, Kejuan Li, Qi Li, et al.
PubMed (2023) Vol. 15, Iss. 12, pp. 6988-7012
Closed Access | Times Cited: 1
Ruijiao Yuan, Kejuan Li, Qi Li, et al.
PubMed (2023) Vol. 15, Iss. 12, pp. 6988-7012
Closed Access | Times Cited: 1
Upregulated HMGB3 resulting in the poor prognosis of lung adenocarcinoma by activating stromal angiogenesis through immune microenvironment
Research Square (Research Square) (2023)
Open Access
Research Square (Research Square) (2023)
Open Access
WITHDRAWN: Upregulated HMGB3 resulting in the poor prognosis of lung adenocarcinoma by activating stromal angiogenesis through immune microenvironment
Weirong Feng, Xiaoming Bai
Research Square (Research Square) (2022)
Open Access
Weirong Feng, Xiaoming Bai
Research Square (Research Square) (2022)
Open Access
